Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
Quoin's paper on QRX003 mechanism of action and a pediatric Netherton Syndrome case report accepted for publication in Dermatology and Therapy.
Quoin's paper on QRX003 mechanism of action and a pediatric Netherton Syndrome case report accepted for publication in Dermatology and Therapy.